This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08639/identifier/chemspider/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08639/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08639/identifier/pubchem-compound/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08639/identifier/pubchem-substance/
n5http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/drug/DB08639/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08639
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n12:DB08639 n14:DB08639
dcterms:title
4-[4-(2,4,6-TRIMETHYL-PHENYLAMINO)-PYRIMIDIN-2-YLAMINO]-BENZONITRILE
adms:identifier
n4:DB08639 n8:TPB n9:185837 n10:214347 n13:99445110
n5:IUPAC-Name
n6:271B4538-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B453E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B453D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B453A-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B453B-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B453C-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4536-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4534-363D-11E5-9242-09173F13E4C5 n6:271B4537-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4535-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4544-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4545-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B453F-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4540-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4542-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4541-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4543-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B454A-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B454C-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B454D-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4549-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4548-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B454B-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4539-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4546-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4547-363D-11E5-9242-09173F13E4C5